COPD, Emphysema, Lung Diseases
Conditions
Brief summary
Researchers are trying to test the effectiveness and feasibility of a multicomponent lifestyle intervention to support weight loss decreases dyspnea in obese people with chronic lung disease and clinically significant breathlessness.
Detailed description
Patient will be randomized to a 12-week intervention that uses the Weight watchers lifestyle program online, a Garmin Fitness Tracker, blue tooth scale and receive health coaching vs a wait-list control group.
Interventions
Patients with lung disease and a BMI of 35 or greater who suffer from shortness of breath will be invited to participate in a study involving a commercial weight loss application with health coaching. The patients will subscribe on their own to the weight loss application. The patients will be provided with a blue tooth scale so that they may weigh themselves weekly. A health coach will call them weekly for 8 weeks.
Participants will receive usual care for 12 weeks followed by the active intervention.
Sponsors
Study design
Intervention model description
Patients with lung disease and a BMI of 35 or greater with significant shortness of breath will be randomized to a multicomponent intervention vs a wait-list control group.
Eligibility
Inclusion criteria
* Age ≥ 18 years. * BMI \>=35 * Dyspnea MRC class II or greater * Diagnosis of lung disease * Signed informed consent
Exclusion criteria
* BMI \<35 * Pregnancy * Recent respiratory illness (within the last 6 weeks) * Recent exacerbation of chronic lung disease (within the last 6 weeks) * Already participating in a structured diet and/or exercise program * Medical contraindication to weight loss (cancer) * Medical contraindication to unsupervised exercise (unstable angina)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Breathlessness | baseline to 12 weeks | Chronic Respiratory Questionnaire Dyspnea |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Percent Body Fat using InBody 770 Scale | baseline to 12 weeks | InBody770 analyzer to define percent body fat |
| Lean Body Mass (lbs.)using InBody 770 Scale | baseline to 12 weeks | InBody770 analyzer to define Lean Body Mass (total body weight minus weight of fat). This measure includes organs, skin, bones, water and muscle. |
| Skeletal Muscle Mass (lbs.) using InBody 770 Scale | baseline to 12 weeks | InBody770 analyzer to define skeletal muscle mass (total weight of muscle) |
| Body Mass Index using InBody 770 Scale | baseline to 12 weeks | InBody770 analyzer to define Body Mass Index (BMI) is weight in kilograms divided by height in meters squared. A BMI of 25 or below is considered healthy. |
| Mindful Eating | baseline to 12 weeks | Mindful Eating Questionnaire- 28 item instrument with a score range of 1-4. Higher scores are associated with lower body mass indexes. |
| Daily Steps | baseline to 12 weeks | Number of steps participant takes in a day recorded by Actigraph Activity tracker. |
| Weight using InBody 770 Scale | baseline to 12 weeks | InBody770 analyzer to define weight |
| Daily Physical Activity | baseline to 12 weeks | Actigraph Activity Tracker to define the amount of time spent in mild to moderate and vigorous physical activity define by METs |
| Exercise Capacity | baseline to 12 weeks | Six-Minute Walking Test |
| Sleep Time Measures | baseline to 12 weeks | Actigraph to measure total sleep time |
| Sleep Efficiency | baseline to 12 weeks | Time sleeping/ Time reclined |
| Disease specific quality of life | baseline to 12 weeks | Chronic Respiratory Questionnaire measures Fatigue , Emotions and Mastery and is a 20 item questionnaire with a range of 1-7. A higher score is best. |
| Daily Sedentary Time | baseline to 12 weeks | Actigraph Activity Tracker to determine the amount of time (minutes) spend sedentary status |
Countries
United States